T. Rowe Price Associates’s OrthoPediatrics KIDS Stock Holding History

T. Rowe Price Associates’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$177K	Buy	11,147 +505	+5%	+$8.82K	﹤0.01%	2877
2025 Q4	$190K	Buy	+10,642	New	+$186K	﹤0.01%	2824
2021 Q4	–	Sell	-6,461	Closed	-$423K	–	3015
2021 Q3	$423K	Hold	6,461	–	–	﹤0.01%	2451
2021 Q2	$408K	Buy	6,461 +318	+5%	+$18.3K	﹤0.01%	2472
2021 Q1	$299K	Sell	6,143 -11	-0.2%	-$528	﹤0.01%	2565
2020 Q4	$254K	Buy	+6,154	New	+$282K	﹤0.01%	2486

Other funds holding KIDS

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates's KIDS Position: Q1 2026 in Review

T. Rowe Price Associates increased its OrthoPediatrics (KIDS) stake by 4.7% in Q1 2026, buying an estimated $8.82K and bringing the position to 11,147 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #2877.

T. Rowe Price Associates first reported a position in KIDS in Q4 2020 and has held it in 6 quarters since. The position peaked at $423K in Q3 2021. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

T. Rowe Price Associates held 11,147 shares of OrthoPediatrics worth $177K as of Q1 2026.
T. Rowe Price Associates bought 505 OrthoPediatrics shares in Q1 2026, an estimated $8.82K.
OrthoPediatrics made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2877 holding.
T. Rowe Price Associates first reported a position in OrthoPediatrics in Q4 2020 and has held it in 6 quarters since.
T. Rowe Price Associates's OrthoPediatrics position peaked at $423K in Q3 2021.
121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.